Klaus Sindahl – Biography

Last update: March 28, 2026

Executive profile

Klaus was Business Development Director at Royal Unibrew, and Senior Manager, Investor Relations at Novozymes.

Klaus Sindahl is currently

Head of Investor Relations at Embla Medical - View - Embla Medical org chart



Create your alert
to follow the career of Klaus Sindahl.

Education

Klaus Sindahl has a Corporate Strategy Degree from Massachusetts Institute of Technology - Sloan School of Management.

They have also studied at Massachusetts Institute of Technology - Sloan School of Management :

Find more alumni from Massachusetts Institute of Technology - Sloan School of Management

More about Klaus Sindahl

The colleagues of Klaus Sindahl

Company Colleagues
Industry Colleagues
  • In the Healthcare industry, Klaus Sindahl has 54,706 colleagues in 3,502 companies located in 59 countries. 39,527 executive movements have been recorded in the last 12 months. Learn more about Healthcare.

Report an error
Update the org chart details of Klaus Sindahl.

Get in Touch

Here are a few tips for establishing great contacts.

Through the switchboard, call Embla Medical at +354... and ask for Klaus Sindahl.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.